Rabbit Huntingtin Interaction Sampler Kit Monoclonal Antibody

Rabbit Huntingtin Interaction Sampler Kit Monoclonal Antibody

Cat. No.: DAB-0012150

Size: 20 µL Size: 100 µL Size: Customer Size
Product Information
Clonality Monoclonal
Host Species Rabbit
Product Description Monoclonal antibodies are produced by immunizing animals with a synthetic peptide corresponding to the residues surrounding Asp69 of human PPARγ, amino terminus of the human CtBP1 protein, full-length human p53 fusion protein, amino terminus of human SUMO-1, or residues surrounding Ile415 of mouse NF-kB1 P105/p50 protein. Polyclonal antibodies are produced by immunizing animals with a synthetic peptide corresponds to the residues surrounding Met864 of human ACF1 protein. Antibodies are purified by protein A and peptide affinity chromatography.
Format Liquid
Purity Affinity purity
Target Information
Gene Description Peroxisome proliferator-activated receptor gamma is a member of the ligand-activated nuclear receptor superfamily and functions as a transcriptional activator. Besides its role in mediating adipogenesis and lipid metabolism, PPAR gamma also modulates insulin sensitivity, cell proliferation and inflammation. CtBP1 is able to regulate gene activity through its intrinsic dehydrogenase activity and by interacting with Polycomb Group proteins during development. Along with its homologue, CtBP2, it acts as a transcriptional corepressor of zinc-finger homeodomain factor deltaEF1 to regulate a wide range of cellular processes through transrepression mechanisms. The p53 tumor suppressor protein plays a major role in cellular response to DNA damage and other genomic aberrations. Activation of p53 can lead to either cell cycle arrest and DNA repair or apoptosis. DNA damage induces phosphorylation of p53 at Ser15 and Ser20 and leads to a reduced interaction between p53 and its negative regulator, the oncoprotein MDM2. MDM2 inhibits p53 accumulation by targeting it for ubiquitination and proteasomal degradation. Phosphorylation impairs the ability of MDM2 to bind p53, promoting both the accumulation and activation of p53 in response to DNA damage. Acetylation appears to play a positive role in the accumulation of p53 protein in stress response. Deacetylation of p53 occurs through interaction with the SIRT1 protein, a deacetylase that may be involved in cellular aging and the DNA damage response. Small ubiquitin-related modifier 1, 2 and 3 are members of the ubiquitin-like protein family. The covalent attachment of the SUMO-1, -2 or -3 to target proteins is analogous to ubiquitination. Ubiquitin and the individual SUMO family members are all targeted to different proteins with diverse biological functions. Ubiquitin predominantly regulates degradation of its target. In contrast, SUMO-1 is conjugated to RanGAP, PML, p53 and IkB-alpha to regulate nuclear trafficking, formation of subnuclear structures, regulation of transcriptional activity and protein stability. Transcription factors of the nuclear factor kappaB /Rel family play a pivotal role in inflammatory and immune responses. In unstimulated cells, NF-kB is sequestered in the cytoplasm by IkB inhibitory proteins. NF-kB-activating agents can induce the phosphorylation of IkB proteins, targeting them for rapid degradation through the ubiquitin-proteasome pathway and releasing NF-kB to enter the nucleus where it regulates gene expression. ACF1 has distinct roles in development, regulation of chromatin structure, and DNA damage response. Different developmental stages dictate the expression of ACF1 in Drosophila, and alterations in ACF1 expression during Drosophila development leads to deviation from normal chromatin organization.
Shipping & Storage
Shipping Shipped at 4 °C.
Storage Instructions Store at +4 °C short term (1-2 weeks). Store at -20 °C long term.
Storage Buffer Constituent: 100% PBS
All of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Related Products
logo

Ace Therapeutics has a team of wellknown experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.

Quick Links
Contact Info
Copyright © Ace Therapeutics. All Rights Reserved.
Top